Somatostatin receptor scintigraphy in gastrinomas

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Jensen, R T ^a   Gibril, F ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Gastrinomas; Imaging; Pancreatic endocrine tumour; Zollinger Ellison syndrome

Indexed keywords

OCTREOTIDE; PENTETATE INDIUM IN 111; SOMATOSTATIN RECEPTOR;

ANGIOGRAPHY; BONE METASTASIS; BONE SCINTISCANNING; CARCINOID; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOCRINE TUMOR; ENDOSCOPIC ECHOGRAPHY; GASTRINOMA; HUMAN; INTERMETHOD COMPARISON; LIVER HEMANGIOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; SCINTIGRAPHY; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; ZOLLINGER ELLISON SYNDROME;

ANGIOGRAPHY; BONE NEOPLASMS; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRINOMA; HEMANGIOMA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; OCTREOTIDE; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY;

EID: 0032750725     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jensen RT. Peptide therapy. Recent advances in the use of somatostatin and other peptide receptor agonists and antagonists. In: Lewis JH, Dubois A, editors. Current clinical topics in gastrointestinal pharmacology. Maiden, MA: Blackwell Science, Inc.; 1997. p. 144-223.
2. Fraker DL, Jensen RT. Pancreatic endocrine tumours. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 5th ed. Philadelphia: Lippincott Raven; 1997. p. 1678-704.
3. Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, editors. The pancreas: Biology, pathobiology and disease. 2nd ed. New York: Raven Press; 1993. p. 931-78.
4. Orbuch M, Doppman JL, Strader DB, Fishbeyn VA, Benya RV, Metz DC, et al. Imaging for pancreatic endocrine tumour localization: recent advances. In: Mignon M, Jensen RT, editors. Endocrine tumours of the pancreas: Recent advances in research and management. Series: Frontiers of gastrointestinal research. Vol. 23. Basel: S. Karger; 1995. p. 268-81.
5. Strader DB, Doppman JL, Orbuch M, Fishbeyn VA, Benya RV, Jensen RT, et al. Functional localization of pancreatic endocrine tumours. In: Mignon M, Jensen RT, editors. Endocrine tumours of the pancreas: Recent advances in research and management. Series: Frontiers of gastrointestinal research. Vol. 23. Basel: S. Karger; 1995. p. 282-97.
6. Reubi JC, Laissue J, Waser B, Horisberger U, Schaer JC. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci 1994 ;733:122-37.
7. Krenning EP, Kwekkeboom DJ, Oei HY, de Jong RJB, Dop FJ, Reubi JC, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumours. Ann N Y Acad Sci 1994;733:416-24.
8. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-31.
9. Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA, et al. Value of somatostatin receptor scintigraphy: A prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997;112:335-47.
10. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 1996;125:26-34.
11. Termanini B, Gibril F, Doppman JL, Reynolds JC, Stewart CA, Sutliff VE, et al. Somatostatin receptor scintigraphy, a new agent to distinguish small hepatic hemangiomas from vascular liver metastases in patients with gastrinomas. Radiology 1997;202:151-8.
12. Gibril F, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F, et al. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and MRI in their detection, their frequency, location and effect of their detection on management. J Clin Oncol 1997;16:1040-53.
13. Gibril F, Fraker DL, Alexander HR, Termanini B, Stewart CA, Sutliff VE, et al. Does the use of preoperative somatostatin receptor scintigraphy (SRS) have an impact in improving postoperative cure rate in patients undergoing surgery with Zollinger-Ellison syndrome (ZES): a prospective study. Gastroenterology 1996;110:A391.
14. Gibril F, Yu F, Sutliff VE, Serrano J, Jensen RT. Is gastrinoma size or location an important determinant of the somatostatin receptor scintigraphy (SRS) result: a prospective study. Gastroenterology 1997;112:A444.
15. de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, le Guludec D, Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 1994;21:1191-7.
16. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumours. N Engl J Med 1990;323:1246-9.
17. Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, le Guludec D, et al. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Gut 1997;41:107-14.
18. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumours. J Nucl Med 1997;38:853-8.
19. Barton JC, Hirschowitz BI, Maton PN, Jensen RT. Bone metastases in malignant gastrinoma. Gastroenterology 1986;91:1179-85.
20. Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996;111:845-54.
21. Ruszniewski P, Amouyal P, Amouyal G, Grange JD, Mignon M, Bouch O, et al. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery 1995;117:629-35.
22. Corleto VD, Scopinaro F, Angeletti S, Materia A, Basso N, Polettini E, et al. Somatostatin receptor localization of pancreatic endocrine tumors. World J Surg 1996;20:241-4.
23. Schillaci O, Scopinaro F, Danieli R, Angeletti S, Tavolaro R, Annibale B, et al. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids. Anticancer Res 1997;17:1753-6.
24. Jensen RT, Norton JA. Endocrine tumours of the pancreas. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease. Vol. 1. 6th ed. Philadelphia: W.B. Saunders; 1998. p. 871-95.
25. Ruszniewski P, Amouyal P, Amouyal G, Cadiot G, Mignon M, Bernades P. Endocrine tumors of the pancreatic area: localization by endoscopic ultrasonography. In: Mignon M, Jensen RT, editors. Endocrine tumours of the pancreas: Recent advances in research and management. Series: Frontiers in gastrointestinal research. Vol. 23. Basel: S. Karger; 1995. p. 258-67.
26. Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV, Jr., Yasuda K, et al. Localization of pancreatic endocrine tumours by endoscopic ultrasonography N Engl J Med 1992;326:1721-6.
27. Jensen RT, Gibril F, Termanini B. Strategic algorithm for neuroendocrine tumor localization based on recent advances and fiscal considerations. Yale J Biol Med 1999;(in press).